Evolus, Inc. (EOLS) Social Stream
EVOLUS INC (EOLS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering EVOLUS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-13 | 7 | $20 | $7 | $15.142 | $10.39 | 45.74% |
| 2022-01-27 | 6 | $20 | $7 | $15.142 | $10.39 | 45.74% |
| 2022-03-04 | 7 | $20 | $7 | $15.142 | $10.39 | 45.74% |
| 2022-04-21 | 7 | $20 | $7 | $15.428 | $10.39 | 48.49% |
| 2022-04-28 | 7 | $20 | $8 | $15.571 | $10.39 | 49.87% |
| 2022-05-11 | 6 | $20 | $8 | $16 | $10.39 | 53.99% |
| 2022-05-12 | 6 | $20 | $10 | $16.333 | $10.39 | 57.2% |
| 2022-10-13 | 7 | $20 | $10 | $16.571 | $10.39 | 59.49% |
| 2022-11-02 | 6 | $20 | $10 | $16.428 | $10.39 | 58.11% |
| 2022-11-09 | 7 | $20 | $10 | $16.428 | $10.39 | 58.11% |
| 2023-01-19 | 7 | $20 | $10 | $16.714 | $10.39 | 60.87% |
The Trend in the Analyst Price Target
EOLS's average price target has moved up $7.04 over the prior 24 months.
EOLS reports an average of 61.11% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-11 | 6 | 20 | 8 | 16.000 | 11.16 | 43.37% |
| 2022-08-01 | 7 | 20 | 10 | 16.571 | 13.11 | 26.4% |
| 2022-10-13 | 6 | 20 | 10 | 16.571 | 8.44 | 96.34% |
| 2022-11-02 | 6 | 20 | 10 | 16.428 | 8.30 | 97.93% |
| 2023-01-19 | 7 | 20 | 10 | 16.714 | 10.52 | 58.88% |
EOLS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.43 | 5 | 1 | 1 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
EOLS's average broker recommendation rating improved by 0 over the prior 153 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- EOLS has a higher average analyst price target than 268.76% of all US stocks.
- In the context of all US stocks, EVOLUS INC's variance in analysts' estimates is lower than -945.39% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, EVOLUS INC's number of analysts covering the stock is greater than 1110.54% of them.
- EOLS has a higher upside potential (average analyst target price relative to current price) than 432.42% of Pharmaceutical Products stocks.
Stocks similar to EVOLUS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ACET, KZIA, and VYNE.
View All Top Stocks by Price Target
Is EOLS a Buy, Hold or Sell? See the POWR Ratings now!